Operating Margin - Schrodinger Inc (NASDAQ:SDGR)

Watchlist Manager

Watchlist

Price: 17.85 USD -0.5%

Market Cap: 1.3B USD

-66.3%

Current

-89%

Average

3.9%

Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin

-66.3%

Operating Profit

-170.5m

Revenue

257m

Operating Margin Across Competitors

Country		Company	Market Cap	Operating Margin
US		Schrodinger Inc NASDAQ:SDGR	1.3B USD	-66%
US		Veeva Systems Inc NYSE:VEEV	37.8B USD	29%
US	C	Cerner Corp LSE:0R00	31.3B USD	13%
AU		Pro Medicus Ltd ASX:PME	24.3B AUD	75%
JP		M3 Inc TSE:2413	1.4T JPY	21%
US		Doximity Inc NYSE:DOCS	8.4B USD	40%
SE		Sectra AB STO:SECT B	52.5B SEK	-19%
US	W	Waystar Holding Corp NASDAQ:WAY	5.5B USD	23%
US		Inspire Medical Systems Inc NYSE:INSP	4.1B USD	4%
IN	I	Inventurus Knowledge Solutions Ltd NSE:IKS	269.1B INR	25%
US	V	Vocera Communications Inc F:V00	2.4B EUR	0%

Schrodinger Inc
Glance View

Economic Moat

None

Market Cap

1.3B USD

Industry

Health Care

In the bustling realm of computational chemistry, Schrödinger Inc. has carved a unique niche, transforming the way pharmaceutical and biotechnology companies approach drug discovery. Founded in 1990, the company has become synonymous with innovation, leveraging powerful physics-based software platforms that simulate molecular interactions at an atomic level. By providing researchers with tools to predict the behavior of complex biological systems, Schrödinger effectively bridges the gap between traditional experimental methods and cutting-edge computational techniques. Their flagship product, the Schrödinger platform, is instrumental in accelerating the drug discovery process, allowing scientists to virtually test countless compounds before selecting the most promising candidates for laboratory synthesis and testing. This capability significantly reduces the time and cost involved in bringing new drugs to market, providing tremendous value to its clients in the pharmaceutical industry. Schrödinger's financial success stems from its diversified business model, which includes software licensing, collaborative research and development projects, and, interestingly, strategic investments in biotech firms. The company licenses its software to a broad range of industries, from pharmaceuticals to materials science, generating a steady stream of revenue. Meanwhile, their collaborative projects enable Schrödinger to participate in revenue sharing or milestone payments based on the compounds developed using their technology. Additionally, by investing in biotech companies utilizing their software, Schrödinger not only fosters innovation but also stands to gain financially from any commercial success. This multifaceted approach not only secures their leadership in the industry but also ensures a robust growth trajectory, as they continue to expand the horizons of computational science.

View SDGR Analysis

SDGR Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

The AI Assistant may sometimes provide inaccurate information.

Make your own investment decisions or consult a licensed financial advisor.

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

S	Scicom (Msc) Bhd KLSE:SCICOM	1.29 MYR -7.19%
	Telecom Plus PLC LSE:TEP	1 396 GBX 1.31%
	Intercede Group PLC LSE:IGP	129.5 GBX -1.52%

	Johnson & Johnson NYSE:JNJ	210.58 USD 1.96%
	Berkshire Hathaway Inc NYSE:BRK.A	743 005 USD 0.99%
	Bank of America Corp NYSE:BAC	54.23 USD 0.28%
	Mastercard Inc NYSE:MA	558.64 USD 3.67%
	UnitedHealth Group Inc NYSE:UNH	336.37 USD 2.44%
	Exxon Mobil Corp NYSE:XOM	119.46 USD -0.07%

	Franklin Covey Co NYSE:FC	16.43 USD 1.67%
	Mohawk Industries Inc NYSE:MHK	112.77 USD 0.96%
	Ardmore Shipping Corp NYSE:ASC	11.31 USD -0.88%
	ASGN Inc NYSE:ASGN	46.48 USD 2.67%
	Skyworks Solutions Inc NASDAQ:SWKS	67.65 USD -1.69%
	Weatherford International PLC NASDAQ:WFRD	81.31 USD 1.51%

Schrodinger Inc
NASDAQ:SDGR